Medical science and technologies in Australia

Medical science and technologies in Australia

utility-emailutility-printutility-pdfContact usChange to standard fontChange to large font

Excellent research facilities, world-class scientists, and a strong but flexible regulatory regime are qualities that have made Australia a global leader in medical science and technologies, offering breakthrough research solutions and partnership opportunities.

From the medical use of penicillin and cochlear implants to more recent breakthroughs in cervical cancer and the bionic eye, Australia has a proven track record and is a world-leading destination for medical research including in biotechnology, pharmaceuticals, diagnostics and clinical trials.

Contact an
investment specialist

Case Studies

Success Stories

View all success stories

Amgen discovers and develops vital medicines Down Under
The US biotech, Amgen, rates Australia as one of the top medical study locations outside the United States.
Read more
Success Story: Carl Zeiss
Carl Zeiss Vision shares Australian research vision
The German optical lens manufacturer is using Australian innovation to both improve the vision of myopia sufferers, and to slow the progression of the condition.
Read more

View all case studies


Investor update

CSIRO performs strongly on global benchmarks
The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national science agency, performs strongly against international benchmarks according to its annual Science Health ...
Janssen invests in medical research at Monash
Global pharmaceutical company Janssen-Cilag, a subsidiary of Johnson & Johnson, has signed a three-year agreement with Australia’s Monash University to undertake collaborative research into autoimmune ...
Takeda partners with Australia’s Monash on gastrointestinal research
Takeda, Japan’s largest pharmaceutical company, and Australia’s Monash University have formed a strategic research alliance to develop new medicines to address significant unmet needs in the treatment ...
Australia positions itself for traditional Chinese medicine market
An agreement has been signed in Canberra which will boost Australia’s position in the A$170 billion global traditional Chinese medicine market.

more updates


Reports and

Why Australia - Benchmark Report

Benchmark Report 2015

The Benchmark Report considers the key investor Indicators of Growth, Innovation, Talent, Location, and Business and compares Australia's position with other countries
Benchmark Report

Data Alerts

Data Alerts provide the latest statistics and figures on Australia's performance across key economic and financial related indicators
Data Alerts

Austrade makes no warranty, express or implied as to the fitness for a particular purpose, or assumes any legal liability for the accuracy or usefulness of any information contained in this document. Any consequential loss or damage suffered as a result of reliance on this information is the sole responsibility of the user.